Glucosylceramide synthase inhibitors
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in 5 combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
18.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in 5 combination with enzyme replacement therapy, cystic disease and for the treatment of cancer. |
---|---|
AbstractList | The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in 5 combination with enzyme replacement therapy, cystic disease and for the treatment of cancer. |
Author | Hirth, Bradford Husson, Herve Bourque, Elyse Scheule, Ronald K Cheng, Seng H Metz, Markus Leonard, John Beskrovnaya, Oxana Makino, Elina Xiang, Yibin Natoli, Thomas Skerlj, Renato Zhao, Zhong Jancsics, Katherine Good, Andrew Cabrera-Salazar, Mario A Celatka, Cassandra Marshall, John |
Author_xml | – fullname: Good, Andrew – fullname: Makino, Elina – fullname: Cheng, Seng H – fullname: Husson, Herve – fullname: Leonard, John – fullname: Celatka, Cassandra – fullname: Marshall, John – fullname: Beskrovnaya, Oxana – fullname: Scheule, Ronald K – fullname: Xiang, Yibin – fullname: Skerlj, Renato – fullname: Jancsics, Katherine – fullname: Cabrera-Salazar, Mario A – fullname: Natoli, Thomas – fullname: Bourque, Elyse – fullname: Zhao, Zhong – fullname: Hirth, Bradford – fullname: Metz, Markus |
BookMark | eNrjYmDJy89L5WRQcc8pTc4vrsxJTi1KzM1MSVUorswryUgsTlXIzMvITMosyS8q5mFgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGlkZGRhYGhk5ORsZEKgMANOcqjw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2019222801BB2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2019222801BB23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 26 04:40:29 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2019222801BB23 |
Notes | Application Number: AU20190222801 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210218&DB=EPODOC&CC=AU&NR=2019222801B2 |
ParticipantIDs | epo_espacenet_AU2019222801BB2 |
PublicationCentury | 2000 |
PublicationDate | 20210218 |
PublicationDateYYYYMMDD | 2021-02-18 |
PublicationDate_xml | – month: 02 year: 2021 text: 20210218 day: 18 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | GENZYME CORPORATION |
RelatedCompanies_xml | – name: GENZYME CORPORATION |
Score | 3.323479 |
Snippet | The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Glucosylceramide synthase inhibitors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210218&DB=EPODOC&locale=&CC=AU&NR=2019222801B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LS8NAEB5KFfWmVfFVySHkFmweTZNDEfOyCLZFWumt7K4bGqixNBHpv3dmSbUnvS27MLs7MDP7zc4DQOeWcDrCs80sY75Jre5N5gnb5AztHZcWFa2iaIuhN5i6T7PurAHLbS6MqhP6pYojokQJlPdK6evVrxMrVrGV5R3PcerjPp30Y6NGx4RfUJzjsJ-MR_EoMqIIkaQxfCFXYEDOjo4VosLeo4c0VdpPXkPKS1ntGpX0GPbHSK-oTqAhixYcRtveay04eK6_vHFYS195Cvqjii_fLIVcs3c8vVZuimqBdkjLi0XOc-qccwZ6mkyigYnbzX9uN3-Y7pwttJ1zaCLwlxeg9Zjrc08yxmXmIhLjwZvTC7q2YBKZ6LFLaP9J6uqf9Ws4IpZRDLLl30CzWn_KNprYit8qznwDZW1_CA |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LS8NAEB5KFetNq-KrmkPILdg8msehiEkao7ZpkVR6C7vphgZqLE1E-u-dDan2pLdlF2Z3B2Zmv9l5AIhUSbRuYqhymhJL5q3uZWIkqkwJ2jvKFF60ikdbhEYw1Z9nvVkDlttcmKpO6FdVHBElKkF5Lyt9vfp1YnlVbGVxRzOc-rj3o74n1eiY4xcUZ8_pDyZjb-xKrotIUgpfuSvQ5s6OruKgwt4zeX1e_nh6c3heymrXqPhHsD9Benl5DA2Wt6HlbnuvteFgVH9547CWvuIExMcqvnyzTNiavOPphWKTlwu0Q0KWLzKa8c45pyD6g8gNZNwu_rld_DDdOZujamfQRODPzkEwiW5RgxFCWaojEqP2XDPtnpoQhkw0yAV0_iR1-c_6LbSCaDSMh0_hyxUccvbxeGTFuoZmuf5kHTS3Jb2puPQNfoqB9Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Glucosylceramide+synthase+inhibitors&rft.inventor=Good%2C+Andrew&rft.inventor=Makino%2C+Elina&rft.inventor=Cheng%2C+Seng+H&rft.inventor=Husson%2C+Herve&rft.inventor=Leonard%2C+John&rft.inventor=Celatka%2C+Cassandra&rft.inventor=Marshall%2C+John&rft.inventor=Beskrovnaya%2C+Oxana&rft.inventor=Scheule%2C+Ronald+K&rft.inventor=Xiang%2C+Yibin&rft.inventor=Skerlj%2C+Renato&rft.inventor=Jancsics%2C+Katherine&rft.inventor=Cabrera-Salazar%2C+Mario+A&rft.inventor=Natoli%2C+Thomas&rft.inventor=Bourque%2C+Elyse&rft.inventor=Zhao%2C+Zhong&rft.inventor=Hirth%2C+Bradford&rft.inventor=Metz%2C+Markus&rft.date=2021-02-18&rft.externalDBID=B2&rft.externalDocID=AU2019222801BB2 |